A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.

Gugliotta G, Argnani L, Cantelli M, Pinto A, Gorgone A, Piazza F, Fozza C, Fesce VF, Marino F, Celli M, Pennese E, Gaudio F, Lauzzana P, Pezzullo L, Lorenzo S, Nierychlewska PM, Ceparano G, Pane F, Casadei B, Pellegrini C, Romano C, Zinzani PL

Open source

DOI: 10.1002/ajh.70317
Published: 2026 Jul
Container: American journal of hematology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ajh.70317,
  title = {A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.},
  author = {Gugliotta G and Argnani L and Cantelli M and Pinto A and Gorgone A and Piazza F and Fozza C and Fesce VF and Marino F and Celli M and Pennese E and Gaudio F and Lauzzana P and Pezzullo L and Lorenzo S and Nierychlewska PM and Ceparano G and Pane F and Casadei B and Pellegrini C and Romano C and Zinzani PL},
  year = {2026},
  journal = {American journal of hematology},
  doi = {10.1002/ajh.70317},
  url = {https://doi.org/10.1002/ajh.70317}
}

RIS

TY  - JOUR
TI  - A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.
AU  - Gugliotta G
AU  - Argnani L
AU  - Cantelli M
AU  - Pinto A
AU  - Gorgone A
AU  - Piazza F
AU  - Fozza C
AU  - Fesce VF
AU  - Marino F
AU  - Celli M
AU  - Pennese E
AU  - Gaudio F
AU  - Lauzzana P
AU  - Pezzullo L
AU  - Lorenzo S
AU  - Nierychlewska PM
AU  - Ceparano G
AU  - Pane F
AU  - Casadei B
AU  - Pellegrini C
AU  - Romano C
AU  - Zinzani PL
PY  - 2026
JO  - American journal of hematology
DO  - 10.1002/ajh.70317
UR  - https://doi.org/10.1002/ajh.70317
ER  -

APA

G, G., L, A., M, C., A, P., A, G., F, P., C, F., VF, F., F, M., M, C., E, P., F, G., P, L., L, P., S, L., PM, N., G, C., F, P., B, C., C, P., C, R., & PL, Z. (2026). A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.. American journal of hematology. https://doi.org/10.1002/ajh.70317

Source records

pubmed · retrieved 2026-09-26T21:55:06.002Z